Ligne de temps

01 janv. 2022
publication

Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study.

Lire plus
16 déc. 2020
publication

Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.

Lire plus